Kulasekararaj A, Brodsky R, Schrezenmeier H, Griffin M, et al. Ravulizumab demonstrates long-term efficacy, safety and favorable patient survival in patients with paroxysmal nocturnal hemoglobinuria. Ann Hematol 2025;104:81-94.
PMID: 39841198